Creo Medical Grp Stock Cash And Equivalents
| 1RC Stock | EUR 0.21 0.01 4.55% |
CREO MEDICAL GRP fundamentals help investors to digest information that contributes to CREO MEDICAL's financial success or failures. It also enables traders to predict the movement of CREO Stock. The fundamental analysis module provides a way to measure CREO MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CREO MEDICAL stock.
CREO |
CREO MEDICAL GRP Company Cash And Equivalents Analysis
CREO MEDICAL's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
In accordance with the recently published financial statements, CREO MEDICAL GRP has 0.0 in Cash And Equivalents. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Cash And Equivalents (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
About CREO MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CREO MEDICAL GRP's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CREO MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CREO MEDICAL GRP based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in CREO Stock
CREO MEDICAL financial ratios help investors to determine whether CREO Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CREO with respect to the benefits of owning CREO MEDICAL security.